secwatch.observer — SEC 8-K summary
======================================

Issuer:     Zura Bio Ltd (ZURA)
CIK:        0001855644
Form:       8-K
Filed at:   2026-06-18T21:00:51+00:00
Accession:  0001104659-26-075826
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve amended equity plan at annual meeting, re-elect directors
------------------------------------------------------------------------------

- Amended 2023 Equity Incentive Plan approved: 38.9M for, 17.4M against, 18.3M broker non-votes.
- Plan share reserve set at 9,594,213; annual evergreen increase of 5% of outstanding shares through 2029.
- All eight director nominees elected; Jennifer Jarrett (16.5M against) and Amit Munshi (16.0M against) had notable opposition.
- Ratification of WithumSmith+Brown, PC as auditor for FY2026 passed with 74.3M votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1855644/000110465926075826/0001104659-26-075826-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1855644/000110465926075826/tm2618327d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-075826

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer